We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $108B
1-Year Est. Return 37.29%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+37.29%
3 Year Est. Return
+69.2%
5 Year Est. Return
+43.82%
10 Year Est. Return
AUM
$23.2B
AUM Growth
+$4.57B
Cap. Flow
+$933M
Cap. Flow %
4.01%
Top 10 Hldgs %
24.47%
Holding
3,215
New
812
Increased
777
Reduced
812
Closed
734

Top Buys

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$286M
2
CI icon
Cigna
CI
+$183M
3
HON icon
Honeywell
HON
+$156M
4
COP icon
ConocoPhillips
COP
+$150M
5
ABT icon
Abbott
ABT
+$120M

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.16%
2 Technology 13.42%
3 Consumer Discretionary 11.26%
4 Financials 11.11%
5 Healthcare 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAW icon
2026
Vanguard Materials ETF
VAW
$2.94B
$147K ﹤0.01%
829
-411
-33% -$73.5K
MGC icon
2027
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
$147K ﹤0.01%
1,029
+574
+126% +$79.5K
ARR
2028
Armour Residential REIT
ARR
$2.12B
$147K ﹤0.01%
+5,600
New +$158K
RWL icon
2029
Invesco S&P 500 Revenue ETF
RWL
$9.94B
$147K ﹤0.01%
1,926
-300
-13% -$22.8K
JVAL icon
2030
JPMorgan US Value Factor ETF
JVAL
$991M
$145K ﹤0.01%
4,248
+1,200
+39% +$41.2K
ALHC icon
2031
Alignment Healthcare
ALHC
$1.86B
$144K ﹤0.01%
22,662
-96,790
-81% -$923K
VOT icon
2032
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.9B
$143K ﹤0.01%
736
+224
+44% +$42.9K
DHF
2033
BNY Mellon High Yield Strategies Fund
DHF
$165M
$143K ﹤0.01%
66,005
ACTG icon
2034
Acacia Research
ACTG
$444M
$143K ﹤0.01%
37,034
-7,972
-18% -$33.7K
DXLG icon
2035
Destination XL Group
DXLG
$35.5M
$142K ﹤0.01%
+25,790
New +$163K
DBEF icon
2036
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.3B
$142K ﹤0.01%
4,035
-5,422
-57% -$187K
NKLA
2037
DELISTED
Nikola Corporation Common Stock
NKLA
$141K ﹤0.01%
+3,881
New +$255K
FINV
2038
FinVolution Group
FINV
$803M
$141K ﹤0.01%
+33,750
New +$171K
VOOV icon
2039
Vanguard S&P 500 Value ETF
VOOV
$6.71B
$141K ﹤0.01%
958
+96
+11% +$14K
NCZ
2040
Virtus Convertible & Income Fund II
NCZ
$280M
$138K ﹤0.01%
+11,481
New +$144K
BBEU icon
2041
JPMorgan BetaBuilders Europe ETF
BBEU
$9.21B
$137K ﹤0.01%
2,570
-1,878
-42% -$98K
EWQ icon
2042
iShares MSCI France ETF
EWQ
$346M
$136K ﹤0.01%
3,609
-11,892
-77% -$433K
KWY
2043
Kingsway Corp
KWY
$281M
$136K ﹤0.01%
+15,469
New +$136K
MNTK icon
2044
Montauk Renewables
MNTK
$317M
$136K ﹤0.01%
+17,309
New +$176K
MGK icon
2045
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.7B
$136K ﹤0.01%
3,325
+1,540
+86% +$58.4K
FXD icon
2046
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$248M
$136K ﹤0.01%
2,617
-488
-16% -$25.6K
EEX
2047
DELISTED
Emerald Holding
EEX
$136K ﹤0.01%
36,506
+12,462
+52% +$46.6K
ASRT
2048
DELISTED
Assertio
ASRT
$135K ﹤0.01%
1,417
-949
-40% -$71.5K
NGM
2049
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$134K ﹤0.01%
32,838
-4,368
-12% -$20.2K
IGOV icon
2050
iShares International Treasury Bond ETF
IGOV
$1.52B
$134K ﹤0.01%
3,329
+858
+35% +$34.1K

Similar funds

Qube Research & Technologies (QRT)'s Q1 2023 Portfolio in Review

As of Q1 2023, Qube Research & Technologies (QRT) held 3,215 positions worth $23.2B, up 24% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Qube Research & Technologies (QRT) deployed $933M of net new capital in Q1 2023, opening 812 new positions and adding to 777 existing holdings. Its largest new stake was First Republic Bank: 2,786,874 shares worth $39M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $180M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q1 2023 buy was First Republic Bank: 2,786,874 shares worth $39M.
  • Qube Research & Technologies (QRT) added most to Cigna in Q1 2023, an estimated $183M increase.
  • Qube Research & Technologies (QRT)'s biggest Q1 2023 reduction was Apple, cutting an estimated $180M.
  • Qube Research & Technologies (QRT) fully exited Vertex Pharmaceuticals in Q1 2023, selling an estimated $123M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 24% of its $23.2B portfolio in Q1 2023.
  • Qube Research & Technologies (QRT) opened 812 new positions and closed 734 in Q1 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $23.2B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.